BioSpace News Archive

Tevogen Bio, today announced that the U.S. Patent and Trademark Office (USPTO) has granted patent of the pharmaceutical compositions of its investigational SARS-CoV-2 Specific Allogeneic T cell therapy for treatment of COVID-19 (US 11,207,401).

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will present at the 40th Annual J.P. Morgan Healthcare Conference.

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, has completed the previously announced acquisition of ReCept Holdings, Inc.

Siemens Healthineers announces that the U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test,1, 2, 3 providing nationwide access to a new at-home or over-the-counter self-test as COVID-19 testing needs continue to grow for individuals, families, and businesses.

BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, is pleased to announce that its common shares will commence trading on the Toronto Stock Exchange as of the opening of trading on Friday, December 31, 2021.

The global specialty medical chairs market is estimated to experience a notable rise in the span of coming years, says TMR.

The global specialty medical chairs market is estimated to experience a notable rise in the span of coming years, says TMR.

The point-of-care diagnostics market is expected to observe good growth prospects during the forecast period of 2016-2024.

Medical floor mats are introduced to provide long-lasting relief from the aches and pains from standing on hard floor surfaces and provides superior comfort to doctors, surgeons, and technicians.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global proliferative vitreoretinopathy market size is projected to reach US$ 660 Mn, exhibiting growth at 4.0% CAGR during the forecast period of 2018 to 2027, predicts Fact.MR.